|
| Status |
Public on Oct 15, 2021 |
| Title |
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34615655 |
| |
| Submission date |
Oct 15, 2021 |
| Last update date |
Sep 27, 2024 |
| Contact name |
Andrew Lane |
| E-mail(s) |
aalane@partners.org
|
| Phone |
617-632-4589
|
| Organization name |
Dana-Farber Cancer Institute
|
| Street address |
450 Brookline Ave
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02215 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (33)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE184656 |
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis [patients] |
| GSE185982 |
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis [cell line] |
| GSE278318 |
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis [PDX] |
|
| Relations |
| BioProject |
PRJNA771650 |
Less...
More...